Where do Edgewise Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Edgewise Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-38.1%-7.9pp	-34.2%+0.2pp	-30%+1.9pp	-27.4%+0.8pp	-30.3%-5.8pp
Return on assets	-36.2%-7.2pp	-32.3%+0.1pp	-28.7%+1.5pp	-26.3%+0.6pp	-29%-5.5pp
Return on invested capital	-47.1%-9.0pp	-43.1%+5.0pp	-37.5%+3.9pp	-34.2%+1.8pp	-38%-7.0pp
Liquidity
Current ratio	22.6×+1.6×	19.9×-0.1×	26.5×+0.2×	28.9×-1.4×	21×-16.1×
Quick ratio	22.6×+1.6×	19.9×-0.1×	26.5×+0.2×	28.9×-1.4×	21×-16.1×
Cash ratio	1.5×-0.9×	2.2×+0.5×	2.1×-0.2×	2.1×-0.5×	2.4×+0.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$4.60+1.9%	$5.07+2.1%	$5.30+1.6%	$5.61+2.8%	$4.52-26.1%
Valuation
Market capitalization	$3.38B+61.3%	$2.63B+3.9%	$1.71B-31.8%	$1.55B-7.9%	$2.09B+31.1%
Enterprise value	$3.35B+63.5%	$2.57B+3.2%	$1.67B-32.3%	$1.51B-8.1%	$2.05B+30.3%
Price / book	6.9×+2.0×	5×-0.5×	3.1×-2.1×	2.6×-0.7×	4.9×+1.9×
Free cash flow yield	-4.4%+1.3pp	-5.5%-1.1pp	-7.8%-3.4pp	-8.1%-1.9pp	-5.7%+0.5pp
Earnings yield	-5.2%+1.8pp	-6.4%-1.1pp	-9.2%-4.2pp	-9.7%-2.8pp	-7%-0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Edgewise Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Edgewise Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.